Our study analysing the expression of CSC related genes in residual gastric cancer cells after neoadjuvant chemotherapy identified a gene signature with a high prognostic impact composed of GSK3B, the β-catenin gene CTNNB1 and NOTCH2. This evidence concerns the gene NOTCH2 and gastric cancer.